Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Outcomes and Therapeutic Management of Bladder Cancer
| Outcomes and Therapeutic Management of Bladder Cancer |
| Autore | Moschini Marco |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (120 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adjuvant
age anesthesia recovery periods biomarkers bladder cancer chemotherapy clear-cell adenocarcinoma cognitive impairment female FOXA1 gamma-cyclodextrins GATA3 glycogen human epidermal growth factor receptor 2 immunotherapy indoleamine 2,3-dioxygenase intracorporeal neobladder KRT20 methylation molecular markers mRNA muscle-invasive bladder cancer n/a neoadjuvant neuromuscular blockade nodal disease open outcome outcomes PCR pN1 programmed death ligand-1 propensity score radical cystectomy robotic robotic radical cystectomy robotic-assisted SEER program database sex-sparing survival urinary bladder urothelial carcinoma |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557114503321 |
Moschini Marco
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Urological Cancer 2021
| Urological Cancer 2021 |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (328 p.) |
| Soggetto topico |
Chemistry
Research & information: general |
| Soggetto non controllato |
177Lu-PSMA
abiraterone ablation margins advanced urothelial carcinoma AHNAK2 autopsy Bacillus Calmette-Guérin (BCG) biomarker biomarkers biopsy bladder cancer bladder cancer cell lines bladder carcinoma cancer cell migration comparative effectiveness comparative oncology ctDNA decision making diagnosis divergent differentiation docetaxel dog enzalutamide epiplakin epithelial-mesenchymal transition fluorescence confocal microscopy focal therapy frail patients frailty FTY-720 game theory genomic analysis genomic signatures glutaminase Hounsfield units image-guided immune checkpoint inhibitor immune checkpoint inhibitors immunohistochemistry immunotherapy in situ methods inflammation inflammatory indices latent cancer liquid biopsy machine learning magnetic resonance imaging mCRPC metastasectomy metastasis metastatic prostate cancer microenvironment molecular subtypes mortality n/a novel hormonal therapies OIP5 oncological outcomes papillary renal cell carcinoma PD-1 PD-L1 PLK1 positron-emission tomography postoperative complications preclinical studies prediction model preneoplastic lesion prognosis prognostic prognostic factor prognostic index prostate prostate biopsy prostate cancer prostatic atrophy prostatic neoplasms PSA PSMA-RLT psoas muscle radical cystectomy radiosensitisation radiotherapy real-world treatment pattern renal cell carcinoma screening trial sphingosine 1-phosphate receptor 1 stereotactic body radiotherapy survival therapy TRIPOD tumor ecology tumor thrombus tumorigenesis tumour mutational board ultrasonography urinary bladder neoplasms urine urothelial carcinoma variant morphology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576872803321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||